Salvo Health is circulating in business and healthtech major media newsletters this month.
In early August, CEO & Founder Jeff Glueck, alongside co-founders Avi Dorfman and Jason Finger announced in a press release, that we have generated $10.5 million in seed funding—from Threshold Ventures, Torch Capital, and Felicis —a large first round considering the current state of the startup ecosystem.
Following the announcement, Salvo Health was featured in a number of newsletters, articles, and reports on the evolving digital healthcare landscape, as a virtual health clinic set to change the game for those living with chronic GI conditions. Below are a few of the industry-leading newsletters that have published our announcement.
Axios Pro Rata featured Salvo Health under its Venture Capital Deals section, written by Dan Primack, as one of two healthtech start-ups announcing a round of fund, and the only announcing such a high seed funding round.
Fortune’s Term Sheet has featured Salvo Health, and its promising seed funding, despite reporting a decline in VC valuation during the second quarter of 2022. Salvo Health’s promising mission to deliver specialty digital healthcare, as well as its top leadership team, is an exception to the rule.
Salvo Health appears alongside Biofourmis Inc. and Abridge in the Wall Street Journal Pro Venture Capital Newsletter, as healthtech companies that prioritize patient-outcomes, signaling a shift in how we deliver healthcare digitally.
When Jeff Glueck announced our funding, he also announced how we at Salvo Health plan on using the funding. Crain’s Health Pulse Column reports that $10.5 million will help us develop our virtual clinic technology, as well as expand our services. We are currently live in 13 states and serve more than 50% of America, with the intention of becoming available in all 50 states.
Featured in Stat HealthTech is our app-based technology and the features that our members can expect from the Salvo Health platform, including unlimited messaging from a Care Team and custom Care Plan. This kind of specialty care is hard to access in-person and yet completely accessible with Salvo Health.
Salvo Health appears both in the Startup Health funding round up, but also their podcast. In the August 9th edition of StartUp Health Insights, $485M in health innovation funding is reported, with Salvo Health taking top billing.
As we continue to advance our app technology, and expand our offerings to all 60 million Americans living with chronic GI conditions nationwide, Salvo Health wants to continue to spread awareness and influence the digital healthcare industry. We believe that giving visibility to and prioritizing the patient experience ensures mutual success for us and our Salvo Health members.